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Abstract 
Background: Cognitive impairment is a common and debilitating symptom of Parkinson’s 
disease (PD), and its etiology is likely multifactorial. One candidate mechanism is circadian 
disruption. Although there is evidence of circadian abnormalities in PD, no studies have directly 
assessed their association with cognitive impairment. 
Objectives: Investigate whether circadian rest-activity rhythm is associated with cognitive 
function in PD independently of sleep. 
Methods: Thirty-five participants with PD wore wrist actigraph monitors and completed sleep 
diaries for 7 to 10 days, then underwent neuropsychological testing. Rest-activity rhythm was 
characterized using nonparametric circadian rhythm analysis of actigraphy data. Objective sleep 
parameters were also estimated using actigraphy data. Hierarchical regression models assessed 
the independent contributions of sleep and rest-activity rhythm to cognitive performance. 
Results:  Less stable day-to-day rest-activity rhythm was associated with poorer executive, 
visuospatial, and psychomotor functioning, but not with memory. Hierarchical regressions 
showed that interdaily stability’s contribution to cognitive performance was independent of 
sleep’s contributions. While sleep contributed to executive function but not psychomotor or 
visuospatial performance, rest-activity rhythm stability significantly contributed to variance in all 
three of these domains, uniquely accounting for 14.4% to 17.6% of their performance variance. 
Conclusions: Our findings indicate that circadian rest-activity rhythm is associated with 
cognitive impairment independently of sleep. This suggests the possible utility of rest-activity 
rhythm as a biomarker for circadian function in PD. Future research should explore interventions 
to stabilize behavioral rhythms in order to strengthen circadian function, which in turn may 
reduce cognitive impairment in PD. 
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Introduction 
Parkinson’s disease (PD) is characterized by motor disturbance as well as by a range of 
non-motor symptoms [1]. One of the most common and debilitating is cognitive impairment, 
which is present in approximately one third of individuals with PD at time of diagnosis, 
increasing in prevalence and severity with disease duration and progressing to dementia for 
many of these individuals [2]. Even subtle cognitive impairment can have significant impact on 
quality of life for persons with early PD and caregivers. Commonly affected cognitive domains 
in PD without dementia include executive function, attention, visuospatial function, and 
memory, with attention and executive function being prevalent at earlier stages of the disease [3]. 
The etiology of cognitive impairment in PD is likely multifactorial, and identifying mechanisms 
may be important for clinical management. 
A candidate mechanism of cognitive impairment in PD is circadian dysfunction. In 
humans, the circadian system is a network of oscillators with approximately 24-hour cycles that 
regulate biological functions at every level throughout the brain and body. Disruption to this 
system can broadly impact physical, emotional and cognitive health either directly or via its 
influence on sleep [4]. While it is well established that sleep affects cognitive performance [5], 
circadian function likely also affects it independently. For example, rodent studies have 
demonstrated that disrupted rest-activity rhythm contributes to executive dysfunction and 
memory deficits above and beyond the effects of previous night’s sleep [6]. In humans, multiple 
studies document the negative cognitive effects of shift work [7] and jet lag [8], both of which 
feature disrupted circadian rest-activity rhythms. 
Although there is mounting evidence that circadian function is impaired in PD [9], there 
has been no direct assessment of associations between circadian and cognitive impairment in this 
population. A study by Whitehead and colleagues [10] found preliminary evidence for this 
association with a correlation between rest-activity amplitude and Mini-Mental State 
Examination (MMSE) score. The MMSE is a brief dementia screen that does not capture many 
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cognitive impairments common in PD (e.g., executive dysfunction), so more comprehensive and 
domain-specific cognitive assessment is needed. Moreover, it is difficult to conclude a 
specifically circadian role in cognition based only on actigraphic rest-activity data, which reflect 
not only circadian function, but also sleep and sleep-wake timing. Given the known relation 
between sleep and cognitive impairment in PD [11,12], Whitehead et al.’s [10] finding may not 
in fact indicate an independent circadian association with cognition. 
Despite the possible confluence of circadian and sleep contributions to actigraphy 
data, there are advantages to using actigraphy to characterize behavioral rhythms (e.g., non-
invasive, inexpensive), and many investigators are using this method to estimate possible 
circadian dysfunction in PD. For example, studies have found that individuals with PD 
consistently demonstrate lower rest-activity amplitude than their age-matched peers (i.e., 
increased motor activity at night and decreased activity during the day) [10,13,14], as well as 
rest-activity patterns that are more fragmented and less stable [10,14,15]. These rest-activity 
patterns co-occur with dysregulated melatonin, cortisol and peripheral clock gene 
expression [14], which suggests that they include a possible circadian component. Actigraphy’s 
potential for capturing circadian dysfunction suggests that it should not be dismissed as a tool for 
exploring circadian function in PD. Rather, analytic techniques should be applied to assess the 
unique association of circadian with cognitive function independently of sleep. 
In the present study, we assessed associations between circadian rest-activity rhythms and 
multi-domain cognitive function in PD, using analytic techniques to reveal the unique 
association of rest-activity rhythms with cognition independent of sleep.  
Methods 
Thirty-five individuals with idiopathic PD (mean age = 66.2, SD = 7.9; 13 women) were 
recruited from the outpatient Movement Disorders Clinic of the Boston Medical Center. They 
had been assessed as part of a study to test the feasibility of using actigraphy to measure sleep 
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quality in PD [15] and the relation of night-time sleep to cognition [16]. Study procedures were 
approved by the Boston University Institutional Review Board, and participants provided 
informed consent. All participants were right-handed, except for two left-handed individuals, and 
were highly educated (mean years of education = 16.8, SD = 2.4). None of the participants was 
demented as indexed by MMSE scores above 25 and performance on multiple 
neuropsychological tests. They had no history of substance abuse, head injury, or neurologic 
disorders besides PD. Participants had mild-moderate PD severity per scores on the Unified 
Parkinson’s Disease Rating Scale (UPDRS; mean score = 25.1, SD = 9.4). Median Hoehn and 
Yahr stage was 2 (range = 1-3). Mean disease duration was 8.8 years (SD = 5.1). All participants 
were taking medication; we calculated levodopa equivalent dosages (LED) based on 
convention [17]. LED was not significantly correlated with sleep, rest-activity, or cognitive 
variables (r’s < .39, p’s > .54). 
Participants’ overall sleep characteristics were assessed with the Parkinson’s Disease 
Sleep Scale (PDSS), a 15-item self-report questionnaire measuring overall quality of sleep, sleep 
onset and maintenance, insomnia, nocturnal restlessness, nocturnal hallucinations, 
distressing/vivid dreams, nocturia, nocturnal motor symptoms, sleep refreshment, and daytime 
dozing [18]. Participants’ mean score of 105.8 (SD = 20.6) out of a possible 150, where lower 
scores reflect worse symptoms, represents moderate sleep disturbance that is consistent with 
early/moderate PD [18]. PDSS score was not correlated with any rest-activity or cognitive 
variables (r’s < 0.32, p’s > .64). Nine of the 35 participants endorsed “acting out dreams,” one of 
whom had a formal diagnosis of REM sleep behavioral disorder (RBD). Although the sample 
size was too small to detect differences between suspected RBD vs non-RBD participants, visual 
inspection of data suggested that there was no difference in the pattern of association between 
circadian and cognitive variables between these two subgroups. 
            Measures.  
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Sleep diaries. Participants completed daily sleep diaries during a 7- to 10-day period that 
documented bed and rise times. 
Actigraphy—sleep and circadian rest-activity rhythm. Participants wore actigraphs 
(Actiwatch AW-64; Mini Mitter, Sunriver, OR) continuously over the same 7- to 10-day period 
on the non-dominant wrist. These accelerometers recorded raw activity counts in 30-second 
epochs at the rate of 30 Hz. Using a threshold of 40 activity counts within an epoch for “wake” 
and sleep diaries to corroborate bed and rise times, we calculated total sleep time, sleep onset 
latency, wake after sleep onset (i.e., duration of wakefulness during the sleep period), and sleep 
efficiency (i.e., percentage of time in bed spent asleep). We calculated circadian rest-activity 
variables using non-parametric circadian rhythm analyses [19,20]: 
Relative amplitude (RA)—ratio of average activity level during the least active five hours 
to the most active 10 hours of each day. 
Interdaily stability (IS)—ratio of activity level variance within each 24-hour pattern to the 
overall variance, essentially a signal-to-noise measure indicating the degree of 
consistency from day to day. A higher value indicated a more stable rhythm.   
Intradaily variability (IV)—ratio of the mean squares of the difference between 
consecutive hours and the mean squares around the overall mean, a measure of 
fragmentation. A lower value indicated less fragmented rhythm. 
Neuropsychological tests—cognitive performance. Cognition was assessed using 
standardized neuropsychological tests of executive function and attention, memory, psychomotor 
speed, and visuospatial function, as described in Stavitsky et al., 2011 [16]. Tests of executive 
function and attention included Verbal Fluency (FAS and Category-Animals), Ruff Figural 
Fluency, Digit Span Backward, Spatial Span Backward, Trail-Making Test B, and the Stroop 
Color-Word Test. Tests of memory included the California Verbal Learning Test-II (CVLT-II), 
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including List A total, Short Delay Free Recall, Long Delay Free Recall, and Yes/No 
Recognition, and the Brief Visual Memory Test, including Learning, Delayed Recall, and 
Yes/No Recognition (BVMT). Tests of psychomotor speed included Trail Making Test A and 
the Purdue Pegboard Test. Tests of visuospatial function included Benton Judgment of Line 
Orientation, Clock Drawing, and the Money Road-Map Test.     
            Procedures. 
Detailed procedures for recruitment and enrollment are described in Stavitsky et al.’s 
2010 study [15]. Briefly, after participants were screened for eligibility, they began wearing wrist 
actigraphs for the following 7-10 days. They were instructed to wear their actigraphs 
continuously and to not change their daily routines or their medication regimens. After 
actigraphic monitoring, participants underwent neuropsychological testing in the laboratory. 
            Data analyses. 
Participants’ scores on neuropsychological tests were converted to z-scores based on a 
matched normal control sample assessed in a previous study [16]. Z-scores were averaged for 
executive function, psychomotor speed, visuospatial function, and memory to create composite 
scores of each domain. 
To test the hypothesis that rest-activity rhythm contributes to variance in cognitive 
performance independently of sleep, we performed hierarchical regressions with sleep and rest-
activity rhythmicity measures as predictors. To preserve statistical power and to avoid 
multicollinearity, we decided a priori that only variables significantly correlating with cognitive 
performance would be used in the hierarchical regression analysis: 
Sleep variables. Both sleep onset latency (SOL) and sleep efficiency (SE) were 
significantly correlated with executive function (r’s > .427, p’s < .01). We decided to use only 
SE as SOL and SE are highly correlated with each other, and SE is the sleep 
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variable conventionally considered to reflect overall sleep quality [21]. Wake after sleep onset 
and sleep duration did not correlate with cognitive variables, and therefore were not included in 
hierarchical regression analyses. 
Rest-activity rhythm variables. Among the rest-activity rhythm variables, only IS was 
significantly correlated with cognitive variables (r’s > .396, p’s < .05; Table 1). Because both 
endogenous circadian rhythms and environmentally-imposed behavioral schedules (i.e., sleep-
wake timing) contribute to IS, we sought to dissociate these two elements by calculating both the 
interdaily stability of rest-activity rhythms (IS) and the interdaily stability of sleep-wake 
schedules based on sleep diary data (ISSW). Of these, IS was significantly correlated with 
cognitive variables, and ISSW was not (r’s < .251, p’s > .146). Therefore, we used only IS, and 
not ISSW, in the hierarchical regression analyses. 
These hierarchical regression analyses were performed separately with executive 
function, psychomotor speed, and visuospatial function as the model outcomes. Because no sleep 
or rest-activity variables correlated with memory composite scores, we did not perform the 
regressions with memory as the outcome. For each hierarchical regression, the first model 
(Model 1) included only SE, and the second model (Model 2) included SE and IS. 
Results 
With executive function as the outcome (Table 2), Model 1 (SE only) was significant 
(F[1,33] = 7.059, R2 = .181, p = .012), with SE explaining 18.1% of the variance in performance. 
The addition of IS in Model 2 (SE + IS) contributed an additional 14.4% of the variance in 
executive performance, which was significant (F[1,32] = 7.460, R2 = .325, ΔR2 = .144, p = .002). 
Multicollinearity was not a concern, indicated by variance inflation factors (VIF) substantially 
lower than the acceptable threshold of 10 (SE, Tolerance = .997, VIF = 1.003; IS, Tolerance = 
.997, VIF = 1.003). 
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With visuospatial function as the outcome (Tables 3), Model 1 was not significant 
(F[1,33] = 0.301, R2 = .009, p = .591) but Model 2 was (F[1,32] = 3.109, R2 = .163, 
ΔR2 = .154, p = .046), with IS contributing a significant portion of the variance (15.4%) to the 
model. SE did not predict visuospatial function (β = .075, t(34) = .457, p = .651), but IS did (β = 
.393, t(34) = 2.385, p = .023). 
Similarly, Model 1 failed to predict psychomotor speed (F[1,33] = .603, p = 
.443, R2 = .019; Table 4), but Model 2 was significant (F[1,32] = 3.741, R2 = .194, 
ΔR2 = .176, p = .035), with IS uniquely explaining 17.6% of the variance in psychomotor speed. 
SE did not predict psychomotor speed (β = .114, t(34) = .707, p = .485), but IS did (β = 
.420, t(34) = 2.602, p = .014). 
Discussion 
            Among individuals with PD, a more stable circadian rest-activity rhythm was associated 
with better performance on executive, psychomotor, and visuospatial tasks, and sleep did not 
account for these associations. In fact, only rest-activity stability, and not sleep efficiency, was 
significantly associated with psychomotor speed and visuospatial function. We further ruled out 
daily sleep scheduling’s contribution by showing that the interdaily stability of sleep-wake 
timing could not fully explain the association between rest-activity rhythm and cognition. 
Together these findings suggest that endogenous circadian function is likely to be the major 
factor in the observed relation between rest-activity rhythm and cognition. 
One possible mechanism by which circadian function contributes to cognition in PD is 
through its regulation of arousal. Through clock gene expression and suprachiasmatic nucleus 
(SCN, i.e., “master clock”) projections to wake-promoting brain regions, the circadian system 
directly regulates brain arousal, which is required for vigilance, working memory, learning, and 
other cognitive functions [6]. Further, because cognitive function itself follows diurnal 
rhythms of behaviors that are also modulated by the circadian system, a disrupted circadian 
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system may compound the effects of blunted arousal and sleep disturbance through less robust 
time-of-day signaling.  
Our findings add to the accumulating evidence for the interaction between cognitive 
function and the circadian system. It is possible that cognitive impairment may affect daily 
activities and lifestyle, leading to altered daily activity rhythms and circadian regulation. 
Alternatively, altered circadian rhythms can also contribute to cognitive decline in aging and 
neurodegenerative disease. For example, less robust and delayed rest-activity rhythms in older 
women predicted the development of dementia or mild cognitive impairment 5 years later [22]. 
In those at risk for Alzheimer’s disease (AD) by virtue of having an affected parent, there is 
already a detectable phase delay in circadian body temperature rhythm more than ten years prior 
to expected cognitive symptom onset [23]. These prospective findings suggest that circadian 
dysregulation is not merely a symptom of cognitive decline, but rather, a driver of pathogenesis 
[24]. In fact, bright light therapy (BLT), a circadian intervention, was able to attenuate cognitive 
decline in elderly group care residents over the course of one year [25], and a four-week dose of 
BLT was able to improve MMSE scores in individuals with AD dementia [26].   
There has been less evidence for circadian associations with cognitive function in PD, 
and until the present study, none that demonstrated separate contributions from circadian rest-
activity rhythm and sleep. Our findings indicate that actigraphy-derived rest-activity rhythm is 
not merely a proxy for sleep in its association with cognition in PD, but can serve as an 
independent predictor. This finding suggests that in addition to addressing nighttime sleep, there 
may be benefit to directly targeting behavioral rhythms. For example, a behavioral rhythm 
intervention that includes timed bright light therapy, consistent sleep-wake timing (i.e., creating 
the opposite effect induced by shift-work, jet lag, and napping), meal timing, and other activity 
scheduling may help to strengthen circadian entrainment in order to improve rhythm stability. 
Because the circadian system interacts intimately with multiple motor and non-motor systems 
affected in PD, improving rhythm stability may not only improve cognition but “raise the water 
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for all boats,” such as for mood, autonomic function, and sleep. These behavioral interventions 
would be low-risk, easily disseminated, and present no issues of drug interaction or side 
effects—welcome news to individuals with PD given their medication burdens. 
Limitations of the present study include small sample size and limited range of disease 
stage (mild to moderate). A larger sample would allow greater statistical power to control for age 
and for disease duration and severity in our assessment of circadian and sleep contributions to 
cognitive performance in PD. Without a reference group of non-PD participants, we were also 
unable to discern any PD-specific associations between rest-activity rhythm, sleep, and 
cognition. In addition, the potential effects of daily scheduled behaviors and environmental 
conditions (e.g., work, exercise, food intake, and light exposure), as well as participants’ 
chronotype, should be controlled or accounted for.  
Future research should measure circadian function in PD using multiple biomarkers (e.g., 
melatonin secretion, blood pressure), as well as measure sleep architecture (i.e., using 
polysomnography), in order to more fully characterize circadian and sleep associations with non-
motor symptoms of PD. Investigators should also prospectively assess changes in rest-activity 
rhythms and cognition in PD, and test the efficacy of circadian intervention for improving 
cognitive impairment and other non-motor symptoms, with the ultimate goal of improving 
quality of life for those with PD. 
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